We are live on ! Find out more
RGC

Roberts, Glore & Co Portfolio holdings

AUM $364M
1-Year Est. Return 19.54%
This Fund
S&P 500
This Quarter Est. Return
+7.81%
1 Year Est. Return
+19.54%
3 Year Est. Return
+59.43%
5 Year Est. Return
+77.93%
10 Year Est. Return
+273.65%
AUM
$262M
AUM Growth
+$98.6M
Cap. Flow
+$84.7M
Cap. Flow %
32.32%
Top 10 Hldgs %
30.44%
Holding
187
New
46
Increased
125
Reduced
4
Closed
12

Sector Composition

Rank Sector Weight
1 Healthcare 23.35%
2 Technology 13.93%
3 Industrials 11.17%
4 Consumer Staples 7.15%
5 Communication Services 6.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VOO icon
151
Vanguard S&P 500 ETF
VOO
$977B
$247K 0.09%
+838
New +$237K
OZK icon
152
Bank OZK
OZK
$5.59B
$245K 0.09%
+8,035
New +$236K
TAP icon
153
Molson Coors Class B
TAP
$7.75B
$245K 0.09%
+4,555
New +$245K
CB icon
154
Chubb
CB
$135B
$243K 0.09%
+1,565
New +$239K
SLB icon
155
SLB Ltd
SLB
$73.4B
$243K 0.09%
+6,054
New +$216K
CMP icon
156
Compass Minerals
CMP
$1.25B
$242K 0.09%
+3,980
New +$226K
DFS
157
DELISTED
Discover Financial Services
DFS
$237K 0.09%
2,801
-124
-4% -$10.2K
SMG icon
158
ScottsMiracle-Gro
SMG
$3.91B
$237K 0.09%
+2,238
New +$229K
AB icon
159
AllianceBernstein
AB
$3.43B
$231K 0.09%
7,642
+342
+5% +$9.97K
OPPJ
160
WisdomTree Trust WisdomTree Japan Opportunities Fund
OPPJ
$276M
$230K 0.09%
+10,810
New +$227K
MA icon
161
Mastercard
MA
$506B
$230K 0.09%
+771
New +$217K
FFIV icon
162
F5
FFIV
$23.1B
$225K 0.09%
+1,613
New +$227K
ALXN
163
DELISTED
Alexion Pharmaceuticals
ALXN
$224K 0.09%
+2,075
New +$222K
EPD icon
164
Enterprise Products Partners
EPD
$81.7B
$218K 0.08%
+7,759
New +$210K
MXIM
165
DELISTED
Maxim Integrated Products
MXIM
$218K 0.08%
+3,550
New +$207K
LKQ icon
166
LKQ Corp
LKQ
$5.69B
$216K 0.08%
+6,075
New +$206K
CSX icon
167
CSX Corp
CSX
$93.4B
$209K 0.08%
+8,667
New +$205K
WLY icon
168
John Wiley & Sons Class A
WLY
$2.65B
$208K 0.08%
+4,287
New +$199K
WY icon
169
Weyerhaeuser
WY
$17.8B
$208K 0.08%
+6,892
New +$200K
MKC icon
170
McCormick & Company Non-Voting
MKC
$13.7B
$206K 0.08%
+2,432
New +$201K
EMF
171
Templeton Emerging Markets Fund
EMF
$318M
$197K 0.08%
+12,700
New +$194K
RJI
172
DELISTED
AB Svensk Ekportkredit ELEMENTS Linked to the Rogers International Commodity Index-Total Return
RJI
$138K 0.05%
25,625
+11,425
+80% +$59.6K
SAMG icon
173
Silvercrest Asset Management
SAMG
$77.1M
$126K 0.05%
+10,020
New +$126K
JOF
174
Japan Smaller Capitalization Fund
JOF
$322M
$89K 0.03%
+10,034
New +$91.1K
LWAY icon
175
Lifeway Foods
LWAY
$456M
$20K 0.01%
+10,300
New +$21.1K

Similar funds

Roberts, Glore & Co's Q4 2019 Portfolio in Review

As of Q4 2019, Roberts, Glore & Co held 187 positions worth $262M, up 60% from $163M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Roberts, Glore & Co deployed $84.7M of net new capital in Q4 2019, opening 46 new positions and adding to 125 existing holdings. Its largest new stake was Vanguard FTSE All-World ex-US ETF: 18,129 shares worth $974K.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Linde, an estimated $68.7K trimmed.

  • Roberts, Glore & Co's largest Q4 2019 buy was Vanguard FTSE All-World ex-US ETF: 18,129 shares worth $974K.
  • Roberts, Glore & Co added most to Abbott in Q4 2019, an estimated $6.14M increase.
  • Roberts, Glore & Co's biggest Q4 2019 reduction was Linde, cutting an estimated $68.7K.
  • Roberts, Glore & Co fully exited Berkshire Hathaway Class B in Q4 2019, selling an estimated $9.69M.
  • Roberts, Glore & Co's ten largest holdings make up 30% of its $262M portfolio in Q4 2019.
  • Roberts, Glore & Co opened 46 new positions and closed 12 in Q4 2019.
  • Roberts, Glore & Co's portfolio value rose 60% quarter-over-quarter to $262M.

Based on Roberts, Glore & Co's 13F filing for Q4 2019, filed 13 Feb 2020.